WO2009072581A1 - ラクタム化合物又はその塩及びppar活性化剤 - Google Patents
ラクタム化合物又はその塩及びppar活性化剤 Download PDFInfo
- Publication number
- WO2009072581A1 WO2009072581A1 PCT/JP2008/072094 JP2008072094W WO2009072581A1 WO 2009072581 A1 WO2009072581 A1 WO 2009072581A1 JP 2008072094 W JP2008072094 W JP 2008072094W WO 2009072581 A1 WO2009072581 A1 WO 2009072581A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- group
- atom
- salt
- integer
- single bond
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/46—Iso-indoles; Hydrogenated iso-indoles with an oxygen atom in position 1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
Abstract
PPAR活性化剤として有用なラクタム骨格を有する化合物又はその塩を提供する。 式(1)で表されるラクタム化合物又はその塩。 [式中、R1はハロゲン、炭化水素基、カルボキシル基などを示し、Z1はアレーン環又はヘテロ環、Z3は脂環族又は芳香族炭化水素環を示し、Z2は、5~6員窒素原子含有環であり、X1は、C、O、S又はN原子、基-N-C(=O)-又は基-C(=O)-N-を示し、R2は、水素原子又は置換基を有していてもよいアルキル基を示し、R3及びR4はそれぞれ単結合又は二価の脂肪族炭化水素基を示し、少なくとも一方が脂肪族炭化水素基であり、X2及びX3は、単結合、O又はS原子、イミノ基などを示し、A1は、単結合又は置換基を有していてもよいフェニレン基を示し、Y1は水素原子、ハロゲン原子、カルボキシル基などを示し、aは0~5、bは0~2及びcは1~3の整数を示す]
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009544722A JP5632612B2 (ja) | 2007-12-05 | 2008-12-04 | ラクタム化合物又はその塩及びppar活性化剤 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007-315021 | 2007-12-05 | ||
JP2007315021 | 2007-12-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2009072581A1 true WO2009072581A1 (ja) | 2009-06-11 |
Family
ID=40717759
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2008/072094 WO2009072581A1 (ja) | 2007-12-05 | 2008-12-04 | ラクタム化合物又はその塩及びppar活性化剤 |
Country Status (2)
Country | Link |
---|---|
JP (1) | JP5632612B2 (ja) |
WO (1) | WO2009072581A1 (ja) |
Cited By (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010280592A (ja) * | 2009-06-03 | 2010-12-16 | Aska Pharmaceutical Co Ltd | ラクタム化合物又はその塩及びppar活性化剤 |
WO2011107494A1 (de) | 2010-03-03 | 2011-09-09 | Sanofi | Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
WO2011161030A1 (de) | 2010-06-21 | 2011-12-29 | Sanofi | Heterocyclisch substituierte methoxyphenylderivate mit oxogruppe, verfahren zu ihrer herstellung und ihre verwendung als gpr40 rezeptor modulatoren |
WO2012004270A1 (de) | 2010-07-05 | 2012-01-12 | Sanofi | Spirocyclisch substituierte 1,3-propandioxidderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
WO2012004269A1 (de) | 2010-07-05 | 2012-01-12 | Sanofi | ( 2 -aryloxy -acetylamino) - phenyl - propionsäurederivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
WO2012010413A1 (de) | 2010-07-05 | 2012-01-26 | Sanofi | Aryloxy-alkylen-substituierte hydroxy-phenyl-hexinsäuren, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
JP2012512893A (ja) * | 2008-12-18 | 2012-06-07 | メタボレックス, インコーポレイテッド | Gpr120受容体作動薬およびその使用 |
WO2012081570A1 (ja) * | 2010-12-14 | 2012-06-21 | あすか製薬株式会社 | ラクタム化合物又はその塩及びppar活性化剤 |
EP2567959A1 (en) | 2011-09-12 | 2013-03-13 | Sanofi | 6-(4-Hydroxy-phenyl)-3-styryl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
WO2013037390A1 (en) | 2011-09-12 | 2013-03-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
WO2013045413A1 (en) | 2011-09-27 | 2013-04-04 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
JP2013217695A (ja) * | 2012-04-05 | 2013-10-24 | Shimadzu Corp | 質量分析用マトリックスの添加剤 |
WO2016114668A1 (en) | 2015-01-16 | 2016-07-21 | Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno | Method to prepare phenolics from biomass |
EP3184505A1 (en) | 2015-12-22 | 2017-06-28 | Nederlandse Organisatie voor toegepast- natuurwetenschappelijk onderzoek TNO | Method for preparing phenolics using a catalyst |
WO2018172852A1 (en) * | 2017-03-21 | 2018-09-27 | Arbutus Biopharma Corporation | Substituted dihydroindene-4-carboxamides and analogs thereof, and methods using same |
KR101902045B1 (ko) | 2011-07-05 | 2018-09-27 | 바스프 에스이 | 락탐, 활성화제 및 촉매를 함유하는 고체 입자, 상기 고체 입자의 제조 방법, 및 상기 고체 입자의 용도 |
CN110526856A (zh) * | 2019-09-12 | 2019-12-03 | 天津瑞岭化工有限公司 | Dwp205190的合成方法 |
US10513515B2 (en) | 2017-08-25 | 2019-12-24 | Biotheryx, Inc. | Ether compounds and uses thereof |
US10752626B2 (en) * | 2016-07-14 | 2020-08-25 | Shanghai Meton Pharmaceutical Co., Ltd | Iso-citrate dehydrogenase (IDH) inhibitor |
US11071793B2 (en) * | 2014-08-29 | 2021-07-27 | Chdi Foundation, Inc. | Probes for imaging huntingtin protein |
US11236103B2 (en) | 2018-07-27 | 2022-02-01 | Biotheryx, Inc. | Bifunctional compounds |
CN114773162A (zh) * | 2022-03-27 | 2022-07-22 | 江苏壹药新材料有限公司 | 一种4-(3-羟基丙烯基)-2-三氟甲基苯酚的合成方法 |
US11897930B2 (en) | 2020-04-28 | 2024-02-13 | Anwita Biosciences, Inc. | Interleukin-2 polypeptides and fusion proteins thereof, and their pharmaceutical compositions and therapeutic applications |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH11503418A (ja) * | 1995-03-29 | 1999-03-26 | メルク エンド カンパニー インコーポレーテッド | ファルネシル−タンパク質トランスフェラーゼ阻害剤 |
JP2000514061A (ja) * | 1996-06-28 | 2000-10-24 | メルク エンド カンパニー インコーポレーテッド | フィブリノーゲン受容体拮抗物質 |
JP2006516254A (ja) * | 2003-01-06 | 2006-06-29 | イーライ・リリー・アンド・カンパニー | Pparモジュレータとしての縮合ヘテロ環誘導体 |
JP2007514659A (ja) * | 2003-11-25 | 2007-06-07 | イーライ リリー アンド カンパニー | ペルオキシソーム増殖因子活性化受容体の修飾因子 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR19980074060A (ko) * | 1997-03-21 | 1998-11-05 | 김윤배 | 신규한 치환된 3,4-디알콕시페닐 유도체 |
GB0124627D0 (en) * | 2001-10-15 | 2001-12-05 | Smithkline Beecham Plc | Novel compounds |
US7320992B2 (en) * | 2003-08-25 | 2008-01-22 | Amgen Inc. | Substituted 2,3-dihydro-1h-isoindol-1-one derivatives and methods of use |
RU2008103218A (ru) * | 2005-06-29 | 2009-08-10 | Палау Фарма С.А. (Es) | БИЦИКЛИЧЕСКИЕ ПРОИЗВОДНЫЕ КАК ИНГИБИТОРЫ p38-КИНАЗЫ |
US8110681B2 (en) * | 2006-03-17 | 2012-02-07 | The United States Of America As Represented By The Secretary, Department Of Health And Human Services | Compounds for the treatment of spinal muscular atrophy and other uses |
-
2008
- 2008-12-04 JP JP2009544722A patent/JP5632612B2/ja not_active Expired - Fee Related
- 2008-12-04 WO PCT/JP2008/072094 patent/WO2009072581A1/ja active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH11503418A (ja) * | 1995-03-29 | 1999-03-26 | メルク エンド カンパニー インコーポレーテッド | ファルネシル−タンパク質トランスフェラーゼ阻害剤 |
JP2000514061A (ja) * | 1996-06-28 | 2000-10-24 | メルク エンド カンパニー インコーポレーテッド | フィブリノーゲン受容体拮抗物質 |
JP2006516254A (ja) * | 2003-01-06 | 2006-06-29 | イーライ・リリー・アンド・カンパニー | Pparモジュレータとしての縮合ヘテロ環誘導体 |
JP2007514659A (ja) * | 2003-11-25 | 2007-06-07 | イーライ リリー アンド カンパニー | ペルオキシソーム増殖因子活性化受容体の修飾因子 |
Non-Patent Citations (1)
Title |
---|
HALL,I.H. ET AL.: "Effects of N-substituted phthalimide, saccharin, succinimide, and indandione derivatives on the type I and II isoforms of human Tmolt4 T cell IMP dehydrogenase, Research Communications", PHARMACOLOGY AND TOXICOLOGY, vol. 6, no. 1 & 2, 2001, pages 19 - 33 * |
Cited By (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2012512893A (ja) * | 2008-12-18 | 2012-06-07 | メタボレックス, インコーポレイテッド | Gpr120受容体作動薬およびその使用 |
JP2010280592A (ja) * | 2009-06-03 | 2010-12-16 | Aska Pharmaceutical Co Ltd | ラクタム化合物又はその塩及びppar活性化剤 |
WO2011107494A1 (de) | 2010-03-03 | 2011-09-09 | Sanofi | Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
WO2011161030A1 (de) | 2010-06-21 | 2011-12-29 | Sanofi | Heterocyclisch substituierte methoxyphenylderivate mit oxogruppe, verfahren zu ihrer herstellung und ihre verwendung als gpr40 rezeptor modulatoren |
WO2012004270A1 (de) | 2010-07-05 | 2012-01-12 | Sanofi | Spirocyclisch substituierte 1,3-propandioxidderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
WO2012004269A1 (de) | 2010-07-05 | 2012-01-12 | Sanofi | ( 2 -aryloxy -acetylamino) - phenyl - propionsäurederivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
WO2012010413A1 (de) | 2010-07-05 | 2012-01-26 | Sanofi | Aryloxy-alkylen-substituierte hydroxy-phenyl-hexinsäuren, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
JPWO2012081570A1 (ja) * | 2010-12-14 | 2014-05-22 | あすか製薬株式会社 | ラクタム化合物又はその塩及びppar活性化剤 |
WO2012081570A1 (ja) * | 2010-12-14 | 2012-06-21 | あすか製薬株式会社 | ラクタム化合物又はその塩及びppar活性化剤 |
KR101902045B1 (ko) | 2011-07-05 | 2018-09-27 | 바스프 에스이 | 락탐, 활성화제 및 촉매를 함유하는 고체 입자, 상기 고체 입자의 제조 방법, 및 상기 고체 입자의 용도 |
EP2567959A1 (en) | 2011-09-12 | 2013-03-13 | Sanofi | 6-(4-Hydroxy-phenyl)-3-styryl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
WO2013037390A1 (en) | 2011-09-12 | 2013-03-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
WO2013045413A1 (en) | 2011-09-27 | 2013-04-04 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
JP2013217695A (ja) * | 2012-04-05 | 2013-10-24 | Shimadzu Corp | 質量分析用マトリックスの添加剤 |
US11071793B2 (en) * | 2014-08-29 | 2021-07-27 | Chdi Foundation, Inc. | Probes for imaging huntingtin protein |
WO2016114668A1 (en) | 2015-01-16 | 2016-07-21 | Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno | Method to prepare phenolics from biomass |
EP3184505A1 (en) | 2015-12-22 | 2017-06-28 | Nederlandse Organisatie voor toegepast- natuurwetenschappelijk onderzoek TNO | Method for preparing phenolics using a catalyst |
WO2017111595A1 (en) | 2015-12-22 | 2017-06-29 | Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno | Method for preparing phenolics using a catalyst |
US10752626B2 (en) * | 2016-07-14 | 2020-08-25 | Shanghai Meton Pharmaceutical Co., Ltd | Iso-citrate dehydrogenase (IDH) inhibitor |
WO2018172852A1 (en) * | 2017-03-21 | 2018-09-27 | Arbutus Biopharma Corporation | Substituted dihydroindene-4-carboxamides and analogs thereof, and methods using same |
US11098010B2 (en) | 2017-03-21 | 2021-08-24 | Arbutus Biopharma Corporation | Substituted dihydroindene-4-carboxamides and analogs thereof, and methods using same |
US10513515B2 (en) | 2017-08-25 | 2019-12-24 | Biotheryx, Inc. | Ether compounds and uses thereof |
US10927104B2 (en) | 2017-08-25 | 2021-02-23 | Biotheryx, Inc. | Ether compounds and uses thereof |
US11236103B2 (en) | 2018-07-27 | 2022-02-01 | Biotheryx, Inc. | Bifunctional compounds |
CN110526856A (zh) * | 2019-09-12 | 2019-12-03 | 天津瑞岭化工有限公司 | Dwp205190的合成方法 |
CN110526856B (zh) * | 2019-09-12 | 2023-04-07 | 天津瑞岭化工有限公司 | Dwp205190的合成方法 |
US11897930B2 (en) | 2020-04-28 | 2024-02-13 | Anwita Biosciences, Inc. | Interleukin-2 polypeptides and fusion proteins thereof, and their pharmaceutical compositions and therapeutic applications |
CN114773162A (zh) * | 2022-03-27 | 2022-07-22 | 江苏壹药新材料有限公司 | 一种4-(3-羟基丙烯基)-2-三氟甲基苯酚的合成方法 |
Also Published As
Publication number | Publication date |
---|---|
JPWO2009072581A1 (ja) | 2011-04-28 |
JP5632612B2 (ja) | 2014-11-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2009072581A1 (ja) | ラクタム化合物又はその塩及びppar活性化剤 | |
WO2009016841A1 (ja) | オキソピラジン誘導体及び除草剤 | |
MX2008014908A (es) | Compuesto heterociclico nuevo o sal del mismo e intermedio del mismo. | |
MY153910A (en) | BICYCLIC y-AMINO ACID DERIVATIVE | |
MX2009004920A (es) | Nuevos derivados de aminopirimidina como inhibidores de plk1. | |
WO2009020140A1 (ja) | アダマンチルウレア誘導体 | |
WO2008108380A3 (en) | Pyrrole compounds | |
WO2008114817A1 (ja) | 新規なアデニン化合物 | |
EA201070994A1 (ru) | Конденсированное гетероциклическое производное и его применение | |
MX2014000452A (es) | Derivados de azabencimiazol que tiene actividad activadora de la proteina cinasa activada monofosfato de denosina (ampk). | |
RS54618B1 (en) | NEW S-NITROZOGLUTATION REDUCTASE INHIBITORS | |
TW200744659A (en) | Preparation for preventing and ameliorating wrinkle | |
MY153720A (en) | Oxazole compound and pharmaceutical composition | |
WO2008108378A3 (en) | Bicyclic oxomorpholine derivative | |
EA200602060A1 (ru) | Производные пирролидин-2-она и пиперидин-2-она, используемые в качестве ингибиторов 11-бета-гидроксистероид-дегидрогеназы | |
WO2009001817A1 (ja) | 11β-HSD1阻害活性を有する化合物 | |
UA105185C2 (uk) | Піроли | |
WO2008126890A1 (ja) | ヒドラジド化合物およびそれを含有する有害節足動物防除剤 | |
EA017861B9 (ru) | Способ получения 4-оксохинолинового соединения | |
WO2008096829A1 (ja) | 3環系化合物 | |
WO2008140066A3 (en) | Pyridone derivatives as p38a mapk inhibitors | |
WO2008126901A1 (ja) | 含窒素複素環化合物およびそれを含有する医薬組成物 | |
WO2009057784A1 (ja) | 複素環化合物 | |
WO2008136444A1 (ja) | 縮合複素環誘導体 | |
MY169179A (en) | Novel piperidine compound or salt thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08858226 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2009544722 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 08858226 Country of ref document: EP Kind code of ref document: A1 |